A PIPELINE POWERED BYPASSION
PUBLICATIONS AND PRESENTATIONS
Healthcare Resource Use, Intensity, and Costs Among Patients with Heart Failure with Reduced Ejection Fraction Treated with Omecamtiv Mecarbil in GALACTIC-HF
Poster, American College of Cardiology 71st Annual Scientific Session (ACC.22)
Desai NR, et al
Washington, D.C.
April 3, 2022
REDWOOD-HCM Cohort 3: Evidence for Clinical Efficacy of Aficamten in Patients with Obstructive HCM and HF Symptoms Refractory to Maximal Medical Therapy, Including Disopyramide
Poster, American College of Cardiology 71st Annual Scientific Session (ACC.22)
Owens AT, et al
Washington, D.C.
April 2, 2022
Influence of Atrial Fibrillation on Efficacy and Safety of Omecamtiv Mecarbil in Heart Failure: the GALACTIC-HF Trial
European Heart Journal
Solomon SD, Claggett BL, Miao ZM, et al
June 14, 2022
Adverse Drug Effects Across Patients With Heart Failure: A Systematic Review
The American Journal of Managed Care
Butzner M, Riello RJ, Sarocco P, et al
March 14, 2022
Developments in Exercise Capacity Assessment in Heart Failure Clinical Trials and the Rationale for the Design of METEORIC-HF
Circulation: Heart Failure
Lewis DG, Docherty KF, Voors AA, et al
March 3, 2022